No. 1 is SCBGENOME(E) +49.91%
กองทุนเปิดเค โกลบอล เฮลท์แคร์ หุ้นทุน
Shows where this fund stands in its group. Not investment advice · Data as of 16 Nov 2026
K-GHEALTH invests through the master fund JPMorgan Funds – Global Healthcare Fund, Class A (acc) - USD 102.09%
This fund and the master fund each charge their own fees. See the fees section of this page for the actual fees
Data as of 31 Oct 2026 · Top 6 shown, the rest grouped as Other · per JPMorgan fact sheet
Over the past year it was below its group median; over 5 years it returned +0.78% per year (Above the median)
| Return | MDD | |
|---|---|---|
| YTD | +12.34% | −9.77% |
| 1D | +0.82% | 0.00% |
| 1W | +3.18% | −0.09% |
| 2W | +3.36% | −3.39% |
| 1M | +7.63% | −3.39% |
| 3M | +9.05% | −8.47% |
| 6M | +18.42% | −8.47% |
| Return | SD | MDD | Return/SD | |
|---|---|---|---|---|
| 1Y | +14.20% | 16.36% | −9.77% | +0.87 |
| 3Y | +25.55%+7.88%/yr | 15.17% | −22.61% | +0.52 |
| 5Y | +3.96% |
No. 1 is SCBGENOME(E) +49.91%
Past performance is not a guarantee of future results
Tap a year to see its months · * part year
Largest drawdown in the selected period −27.87% Previous peak 20 Feb 2020 (NAV 8.9972) → Trough 23 Mar 2020 (NAV 6.4900) · Back to the previous peak on 18 May 2020, after 1 month
Currently −0.32% from the peak NAV of 11.8928 (5 Nov 2026)
Over 1 year, K-GHEALTH returned 0.87 per unit of SD, ranking 22 of 40 funds · The highest is KFHEALTH-A (1.34)
Paid 3 times in the past 12 months, totalling 0.7000 THB per unit, or 5.90% of NAV
K-GHEALTH pays cash dividends to unitholders from part of the fund's profit. Below is a summary of when you get paid, how much, and how regularly
You must buy and hold units before the book close to receive that round's dividend
The last 4 dividends Nov 24 0.2000 THB · Feb 26 0.2000 THB · Jul 26 0.3000 THB · Nov 26 0.2000 THB, and the next round is about 0.2250 THB on 1 Feb 2027This is not an AMC announcement. The actual date and amount may differ, or no dividend may be paid
THB/unit, totalled by year of payment · * 2026 to 16 Nov 2026
กองทุนมีนโยบายที่จะนำเงินไปลงทุนในต่างประเทศโดยเฉลี่ยรอบระยะเวลาบัญชีไม่น้อยกว่าร้อยละ 80 ของมูลค่าทรัพย์สินสุทธิของกองทุน Its largest holdings are JP Morgan Funds - Global Healthcare Fund (JPHLUAA LX) 102.09% (fact sheet 30 Sep 2026)
Risk level 6 of 8 (High risk). Since 26 Nov 2014, its NAV has fallen as much as −27.87% from its peak.
Actual total expense ratio (TER) 1.75% a year, against a ceiling of 4.01%. Management fee 1.61%. Front-end fee 1.50%. Back-end fee 0.00%. (Fact sheet 31 Aug 2026)
Yes. The latest was 0.2000 THB per unit, book close 2 Nov 2026, paid 13 Nov 2026 · 19 payments so far, totalling 4.2000 THB per unit. Dividends are subject to 10% withholding tax and are not guaranteed
Minimum first purchase 500 THB, subsequent purchases 500 THB. Buy orders accepted until 15:30, sell orders until 14:30, and redemption proceeds are paid T+4
Hedged at the manager's discretion. As of 30 Sep 2026, 93.16% of the value of its foreign investments was hedged
Warning Past performance is not a guarantee of future results · Investing involves risk. Investors should understand the product's features, return conditions and risks before making an investment decision · This fund invests abroad, so investors may lose or gain from exchange rate movements
Diabetes and weight-loss drugs
An American medicines and medical devices company, with products such as cancer drugs and surgical instruments
Hospitals, medicines and medical equipment
Hospitals, medicines and medical equipment
Hospitals, medicines and medical equipment
Based on the master fund's share of this fund's value (102.09% as of 30 Sep 2026) × each stock's weight in the master fund · stocks as of 31 Oct 2026 · fact sheet from JPMorgan · Illustrations are for explanation only, not individual stock recommendations
| 16.69% |
| −22.92% |
| +0.05 |
| 7Y | +49.17%+5.88%/yr | 17.96% | −27.87% | +0.33 |
| 10Y | +90.30%+6.65%/yr | 16.86% | −27.87% | +0.39 |
| MAX | +71.43%+4.60%/yr | 17.22% | −27.87% | +0.27 |
| Return | MDD | SD | Return/SD | |
|---|---|---|---|---|
| 1Y | +14.20% | −9.77% | 16.36% | +0.87 |
| 3Y | +25.55%+7.88%/yr | −22.61% | 15.17% | +0.52 |
| 5Y | +3.96%+0.78%/yr | −22.92% | 16.69% | +0.05 |
| 7Y | +49.17%+5.88%/yr | −27.87% | 17.96% | +0.33 |
| 10Y | +90.30%+6.65%/yr | −27.87% | 16.86% | +0.39 |
| MAX | +71.43%+4.60%/yr | −27.87% | 17.22% | +0.27 |
No. 1 is TBIOTECH +23.13% per year
No. 1 is TBIOTECH +7.82% per year
Each bar is one fund in the AIMC Health Care group, sorted from highest to lowest return · Only No tax benefit share classes are counted, and only funds with a full track record for the period are included · Calculated from NAV as of 16 Nov 2026